Literature DB >> 24692838

Effect of pretreatment with coenzyme Q10 on isoproterenol-induced cardiotoxicity and cardiac hypertrophy in rats.

Arvindkumar E Ghule1, Chetan P Kulkarni1, Subhash L Bodhankar1, Vijaya A Pandit2.   

Abstract

BACKGROUND: Coenzyme Q10 (CoQ10) is a lipid-soluble, vitamin-like substance found in the hydrophobic interior of the phospholipid bilayer of most cellular membranes. It appears to be involved in the coordinated regulation between oxidative stress and antioxidant capacity of heart tissue when the heart is subjected to oxidative stress in various pathogenic conditions.
OBJECTIVE: The objective of the present study was to investigate the effect of pretreatment with CoQ10 (100 mg/kg) on isoproterenol (ISO)-induced cardiotoxicity and cardiac hypertrophy in rats.
METHODS: Albino male Wistar rats (250-300 g) were evenly divided by lottery method into 1 of the following 3 groups: the ISO group (olive oil 2 mL/kg orally for 18 days and ISO 1 mg/kg IP from days 9-18); the CoQ10 + ISO group (CoQ10 100 mg/kg orally for 18 days and ISO 1 mg/kg IP from days 9-18); and the control group (olive oil 2 mL/kg orally for 18 days and water IP from days 9-18). Twenty-four hours after the last dose of water or ISO, the rats were anesthetized and an ECG was recorded. Blood was withdrawn by retro-orbital puncture for estimation of serum creatine kinase-MB (CK-MB) isoenzyme levels, lactate dehydrogenase (LDH) levels, and aspartate aminotransferase activities. The animals were euthanized using an overdose of ether. The hearts of 6 animals from each group were used for estimation of superoxide dismutase (SOD) activity, reduced glutathione (GSH) concentration, lipid peroxidation (LPO), malondialdehyde (MDA), and total protein concentration. Histopathology of the 2 remaining hearts in each group was carried out by a blinded technician.
RESULTS: A total of 24 rats (8 in each group) were used in this study; all rats survived to study end. Compared with the control group, the ISO-treated rats had a significant change in heart to body weight ratio (P < 0.001); significant changes in the endogenous antioxidants (ie, significantly higher myocardial MDA concentration [P < 0.001]; significantly lower myocardial GSH concentration [P < 0.001] and SOD activity [P < 0.01]); and significantly higher serum activities of marker enzymes (eg, CK-MB [P < 0.001] and LDH [P < 0.001]). Compared with the ISO group, the CoQ10 + ISO group had a significant change in heart to body weight ratio (P < 0.001); significant changes in the endogenous antioxidants (ie, significantly lower MDA concentration [P < 0.05]; significantly higher myocardial GSH concentration [P < 0.001] and SOD activity [P < 0.05]); and significantly lower serum activities of marker enzymes (eg, CK-MB [P < 0.05] and LDH [P < 0.01]).
CONCLUSION: Pretreatment with CoQ10 (100 mg/kg) for 18 days was associated with moderate protection against ISO-induced cardiotoxicity and cardiac hypertrophy, and with lower myocardial injury by preserving endogenous antioxidants and reducing LPO in rat heart.

Entities:  

Keywords:  antioxidants; cardiac hypertrophy; coenzyme Q10; isoproterenol

Year:  2009        PMID: 24692838      PMCID: PMC3969979          DOI: 10.1016/j.curtheres.2009.12.004

Source DB:  PubMed          Journal:  Curr Ther Res Clin Exp        ISSN: 0011-393X


  31 in total

1.  Protective effect of coenzyme Q10 on exercise-induced muscular injury.

Authors:  Y Shimomura; M Suzuki; S Sugiyama; Y Hanaki; T Ozawa
Journal:  Biochem Biophys Res Commun       Date:  1991-04-15       Impact factor: 3.575

Review 2.  Beta 1- and beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure.

Authors:  O E Brodde
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

3.  Antioxidant effects of ubiquinones in microsomes and mitochondria are mediated by tocopherol recycling.

Authors:  V Kagan; E Serbinova; L Packer
Journal:  Biochem Biophys Res Commun       Date:  1990-06-29       Impact factor: 3.575

4.  Infarct size and left ventricular ejection fraction in acute myocardial infarction.

Authors:  M Hori; M Inoue; M Mishima; T Shimazu; H Abe; S Fukui; N Ohgitani; T Minamino
Journal:  Jpn Circ J       Date:  1977-11

5.  Cardioprotective effect of fluvastatin on isoproterenol-induced myocardial infarction in rat.

Authors:  Ru Zhou; Qingbin Xu; Ping Zheng; Lin Yan; Jie Zheng; Guidong Dai
Journal:  Eur J Pharmacol       Date:  2008-03-04       Impact factor: 4.432

Review 6.  Mechanisms of alterations in cardiac membrane Ca2+ transport due to excess catecholamines.

Authors:  K S Dhalla; H Rupp; R E Beamish; N S Dhalla
Journal:  Cardiovasc Drugs Ther       Date:  1996-06       Impact factor: 3.727

7.  Effect of garlic (Allium sativum) on lipid peroxidation in experimental myocardial infarction in rats.

Authors:  G Saravanan; J Prakash
Journal:  J Ethnopharmacol       Date:  2004-09       Impact factor: 4.360

8.  Lipid peroxidation and antioxidant enzymes in isoproterenol induced oxidative stress in rat tissues.

Authors:  N Rathore; S John; M Kale; D Bhatnagar
Journal:  Pharmacol Res       Date:  1998-10       Impact factor: 7.658

9.  Chronic oral administration of raw garlic protects against isoproterenol-induced myocardial necrosis in rat.

Authors:  S K Banerjee; S Sood; A K Dinda; T K Das; S K Maulik
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2003-12       Impact factor: 3.228

10.  Catecholamine-induced myocardial cell damage: catecholamines or adrenochrome.

Authors:  A M Wheatley; F T Thandroyen; L H Opie
Journal:  J Mol Cell Cardiol       Date:  1985-04       Impact factor: 5.000

View more
  7 in total

1.  Association between miR-181b and PKG 1 in myocardial hypertrophy and its clinical implications.

Authors:  Wei Zhong; Jun Yang; Qian Cao; Xiaodong Huan
Journal:  Exp Ther Med       Date:  2015-07-20       Impact factor: 2.447

2.  Naringin and Sertraline Ameliorate Doxorubicin-Induced Behavioral Deficits Through Modulation of Serotonin Level and Mitochondrial Complexes Protection Pathway in Rat Hippocampus.

Authors:  Mohit Kwatra; Ashok Jangra; Murli Mishra; Yogita Sharma; Sahabuddin Ahmed; Pinaki Ghosh; Vikas Kumar; Divya Vohora; Razia Khanam
Journal:  Neurochem Res       Date:  2016-05-21       Impact factor: 3.996

3.  Combined therapeutic effects of low power laser (980nm) and CoQ10 on Neuropathic Pain in adult male rat.

Authors:  Seyed Behnamedin Jameie; Masoumeh Masoumipoor; Atousa Janzadeh; Farinaz Nasirinezhad; Mahdieh Kerdari; Maryam Soleimani
Journal:  Med J Islam Repub Iran       Date:  2014-07-13

4.  Coenzyme Q10 prevents oxidative stress and fibrosis in isoprenaline induced cardiac remodeling in aged rats.

Authors:  Anayt Ulla; Mustafe Khalid Mohamed; Biswajit Sikder; Afm Towheedur Rahman; Farzana Akther Sumi; Murad Hossain; Hasan Mahmud Reza; G M Sayedur Rahman; Md Ashraful Alam
Journal:  BMC Pharmacol Toxicol       Date:  2017-04-20       Impact factor: 2.483

Review 5.  Coenzyme Q10 in Cardiovascular and Metabolic Diseases: Current State of the Problem.

Authors:  Vladlena I Zozina; Serghei Covantev; Olga A Goroshko; Liudmila M Krasnykh; Vladimir G Kukes
Journal:  Curr Cardiol Rev       Date:  2018

6.  Role of N-Acetylcysteine and Coenzyme Q10 in the Amelioration of Myocardial Energy Expenditure and Oxidative Stress, Induced by Carbon Tetrachloride Intoxication in Rats.

Authors:  Nayira A Abd Elbaky; Naglaa F El-Orabi; Laila M Fadda; Omar H Abd-Elkader; Hanaa M Ali
Journal:  Dose Response       Date:  2018-08-09       Impact factor: 2.658

7.  Bawei Chenxiang Wan Ameliorates Cardiac Hypertrophy by Activating AMPK/PPAR-α Signaling Pathway Improving Energy Metabolism.

Authors:  Xiaoying Zhang; Zhiying Zhang; Pengxiang Wang; Yiwei Han; Lijun Liu; Jie Li; Yichun Chen; Duxia Liu; Jinying Wang; Xiaoying Tian; Qin Zhao; Fengxia Yan
Journal:  Front Pharmacol       Date:  2021-06-03       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.